What you should know:
1. CEO Tushar Ramani, MD, was appointed board chairman.
2. Independent director Ian Webb will serve as the lead director of the board.
3. Dr. Holler joined the CRH board in 2005.
More articles on ASCs:
Takeda continues non-core asset sell-off for $825M
Philadelphia researchers develop 3D modeling software for previously unviewable portion of colon
FDA awards esophageal DNA test breakthrough device designation
